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OBJECTIVES The study compared a hand-carried echocardiography (HC) device with standard echocar-
diography (SE) in critically ill patients.
BACKGROUND Recently, small HC devices have been introduced, and early reports showed a good
correlation with SE.
METHODS We used HC (SonoSite, Bothell, Washington) echocardiography to evaluate critically ill
patients, and we compared the results with SE obtained with state-of-the-art equipment
(Sonos 5500, Hewlett-Packard, Andover, Massachusetts). Each of 80 critically ill patients
was studied twice (HC and SE). The studies were done and interpreted separately in blinded
fashion.
RESULTS The HC device missed a clinical finding related to the reason for referral in 31% of patients.
In 19% of patients a clinically important finding separate from the indication for echocardi-
ography was also missed. The total number of patients with one or more missed findings was
36 (45%). Findings were missed by HC for several reasons. First, HC does not contain
spectral Doppler, electrocardiographic, or M-mode capabilities. Two-dimensional imaging is
superior on SE, with improved image processing. In addition, although HC does contain
color power Doppler, it does not have true color flow Doppler imaging. Therefore, HC often
failed to detect or accurately quantify valvular regurgitation.
CONCLUSIONS Although the HC device was able to provide important anatomic information, the device falls
far short of SE in the evaluation of critically ill patients. (J Am Coll Cardiol 2001;37:
2019–22) © 2001 by the American College of Cardiology
Portable echocardiograms performed at the bedside can
help the physician to diagnose and manage critically ill
patients. Standard echocardiography (SE) equipment, while
excellent, is large and unwieldy. Because of this it is
sometimes difficult to maneuver in a crowded intensive care
unit (ICU) setting. Additionally, standard machines are
generally housed in the hospital’s echocardiography labora-
tory and are not instantly available for use.
Recently, hand-carried echocardiography (HC) devices
have been introduced (1–6). These devices are attractive
because of their size, portability and cost. They can be kept
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in ICU settings to be immediately available for bedside use.
Our study was designed to compare the diagnostic ability of
a HC device compared to a SE machine when used in
critically ill patients.
METHODS
Emergent portable cardiac echocardiography was per-
formed in 80 consecutive patients located in ICUs (47
patients), stepdown units (21 patients), the recovery room (6
patients) and the emergency room (6 patients). Each patient
had two complete studies performed, one using a SE
machine (Hewlett-Packard [Agilent] Sonos 5500, Andover,
Massachusetts) and the other using a HC device (Sono-
Heart, SonoSite, Bothell, Washington). The transducer on
the HC device is a 15-mm broadband 2- to 4-MHz device.
The two studies were performed within 2 h of each other,
and both were recorded for analysis (SE was recorded on
standard videotape, and HC was recorded on a mini digital
videocassette).
The SE included M-mode, two-dimensional (2D), color
Doppler and spectral Doppler (pulsed and continuous
wave). An electrocardiogram (ECG) was recorded simulta-
neously. The HC included 2D and color power Doppler
(M-mode, ECG, standard color Doppler and spectral
Doppler are not available on this machine). In each case, the
studies (SE and HC) were performed by two different
experienced sonographers who were blinded to the results of
the other examination. For each patient, the two studies
were interpreted by two different experienced echocardio-
graphers, and these interpretations were also blinded.
For the purposes of the present study, SE was considered
to be the gold standard, and results of the SE and HC
studies were compared for each patient. Two comparisons
were performed for each patient. The first was done to
determine the ability of HC to answer the requested clinical
question (the indication for the study). The second served to
determine whether either SE or HC detected any additional
clinically important findings.
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RESULTS
There were 99 clinical questions (indications) from the
referring physicians in the 80 patients studied. These
included left ventricular function (LVF) in 38 patients
(48%), native valve function in 18 patients (23%), pericardial
effusion or tamponade in 16 patients (20%), prosthetic valve
function in 10 patients (13%), possible endocarditis in 5
patients (6%), possible thrombus in 2 patients (3%), dia-
stolic dysfunction in 2 patients (3%) and miscellaneous in 8
patients (10%) (the total is .100% as some patients had
more than one indication for echocardiography).
The HC device was able to evaluate 84 of 99 clinical
questions (85%) (Table 1). Fifteen percent of questions
could not be evaluated because of the HC device’s lack of
spectral Doppler capability. The unanswerable questions
included 10 cases of prosthetic valve function, 2 of diastolic
dysfunction, 1 severity of aortic stenosis, 1 degree of left
ventricular outflow obstruction and 1 constrictive pericardi-
tis. The SE was configured to answer all of the clinical
questions.
Of the 84 clinical questions for which HC was configured
to evaluate, it correctly evaluated 72 questions (86%) and
missed findings relevant to the clinical question in 12 (14%)
as compared with SE (Table 2). The missed clinical findings
included LVF (6 findings), native valve function (4 find-
ings), cardiac tamponade (1 finding) and left atrial thrombus
(1 finding). There were two cases (2%) in which relevant
findings were seen on HC and not on SE (both LVF).
Furthermore, beyond the 99 clinical questions asked, HC
failed to diagnose 17 clinically significant findings in 15
patients (19%) diagnosed by SE (Table 3). The lack of
spectral Doppler was the reason for not seeing four findings
(pulmonary hypertension in three patients, two severe and
one moderate, and the degree of left ventricular outflow
tract obstruction in one patient). For the other 13 findings,
HC had the configuration necessary to diagnose them but
did not. These findings not seen by HC included significant
mitral regurgitation in nine patients (severe in three, mod-
erate to severe in two, and moderate in four), LVF in two
patients, moderate tricuspid insufficiency in one patient and
moderate aortic regurgitation in another.
In summary HC, when compared to SE, did not answer
27% of the 99 clinical questions asked by referring physi-
cians (HC was not configured to answer 15%, and it also
missed 12% of the findings that it was theoretically capable
of detecting). Moreover, SE, and not HC, was able to
diagnose additional clinically significant findings in 19% of
patients. In nearly half of the patients (45%), HC missed
one or more findings (primary and/or additional) (Table 3).
DISCUSSION
Previously reported uses of HC. Small, HC devices have
recently been introduced, with favorable early reports in the
outpatient setting (1), when used on hospital rounds (2),
and in a small cohort of ICU patients (3). It has been shown
to augment the results of physical examination in 25
patients referred for echocardiography (4) and in 35 patients
examined on hospital rounds (2). Some of these reports have
shown a good correlation between HC and SE for the
evaluation of wall motion (5,6) and valvular regurgitation (5).
Limitations of HC compared to SE. However, it is not
surprising that in our cohort of critically ill patients the
results for HC and SE are frequently discordant. Critically
ill patients are often difficult to image because of the
inability to position them well, lack of cooperation, ambient
light, tachypnea, artificial ventilation, surgical wounds, ban-
dages, chest tubes and other factors. The state-of-the-art
equipment used for SE has the ability to overcome some of
these problems. The use of different transducer frequencies
can improve the image, as can the use of second harmonics.
Timing of events in the cardiac cycle is also possible with
SE, which is equipped with both ECG and M-mode
capabilities, and this may aid in the interpretation of
Table 1. Is the Hand-Carried Device Configured to Evaluate
the Clinical Question? (n 5 99)
Yes No
HC 84 (85%) 15 (15%)
SE 99 (100%) 0 (0%)
HC 5 hand-carried echocardiography; SE 5 standard echocardiography.
Table 2. Did the Hand-Carried Device Answer the Clinical
Question for Which It Was Configured? (n 5 84)
Yes No
HC 72 (86%) 12 (14%)
SE 82 (98%) 2 (2%)
HC 5 hand-carried echocardiography; SE 5 standard echocardiography.
Table 3. Patients in Whom Findings Were Missed (n 5 80)
HC SE
Patients with missed 1° finding 25 (31%) 2 (3%)
Device configured 9 (11%) 2 (3%)
Device not configured 15 (19%) 0 (0%)
Both 1 (1%) 0 (0%)
Patients with missed additional finding 15 (19%) 0 (0%)
Device configured 11 (14%) 0 (0%)
Device not configured 2 (3%) 0 (0%)
Both 2 (3%)
Total patients with 1 or more missed
findings (1° and/or additional)
36 (45%) 2 (3%)
1° finding 5 finding related to question raised by referring doctor; HC 5 hand-
carried echocardiography; SE 5 standard echocardiography.
Abbreviations and Acronyms
2D 5 two-dimensional
ECG 5 electrocardiogram
HC 5 hand-carried echocardiography
ICU 5 intensive care unit
LVF 5 left ventricular function
SE 5 standard echocardiography, echocardiograms
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suboptimal images (e.g., timing of color jets and diastolic
collapse of the right heart chambers in tamponade).
Furthermore, color power Doppler (used in HC) lacks
variance, which makes the identification of high-velocity,
turbulent jets more difficult (Fig. 1). Color power Doppler
is a technique that measures the mean amplitude of the
Doppler signal, not the Doppler shift as in standard color
Doppler. Therefore, velocity is not measured and color
Figure 2. Systolic frame, apical four-chamber views in another patient with dyspnea: (A) hand-carried echocardiography (with color power Doppler) (arrow
points to tricuspid regurgitation); (B) standard echocardiography (with color Doppler). Note that severe tricuspid regurgitation was seen easily in the right
atrium by standard echocardiography (B) and not by hand-carried echocardiography (A). In addition, this patient has severe pulmonary hypertension (note
continuous-wave Doppler with a 4-m/s velocity of tricuspid regurgitation [arrow] on standard echocardiography (C); this indicates a pulmonary artery
systolic pressure of approximately 75 mm Hg). This critical information could not be obtained with hand-carried echocardiography, which lacks spectral
Doppler. LA 5 left atrium; LV 5 left ventricle; RA 5 right atrium; RV 5 right ventricle.
Figure 1. Systolic frame, long axis parasternal views in a patient with dyspnea: (A) hand-carried echocardiography (with color power Doppler); (B) standard
echocardiography (with color Doppler). Note that severe mitral regurgitation was seen easily by standard echocardiography (B) and not by hand-carried
echocardiography (A). Ao 5 aorta; LA 5 left atrium; LV 5 left ventricle.
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power Doppler is non-aliasing. Although this may be
advantageous for imaging low-flow states (as in tumor
vessels) it is disadvantageous in imaging valvular regurgitant
jets where aliasing serves to clearly outline these jets (7).
Even in outpatients, one study did not find a good correla-
tion between HC and SE with respect to the diagnosis of
valvular regurgitation (1).
In addition, the footprint of the HC transducer is larger
than that of SE, and this makes it difficult to place it in an
intercostal space for the location of the best echocardio-
graphic window. Furthermore, the lack of spectral Doppler
is an important limitation of HC, as vital clinical findings
such as pulmonary hypertension (Fig. 2), inflow or outflow
obstruction, and signs of restriction or constriction may be
missed without it.
In our study, significant pathology that was not related to
the primary indication for the study was frequently diag-
nosed by SE and missed by HC. For example, a patient
referred for possible left ventricular systolic dysfunction was
found to have normal wall motion on both HC and SE;
however, moderate tricuspid regurgitation and pulmonary
hypertension (pulmonary artery systolic pressure of approx-
imately 60 mm Hg) were found with SE and both were
missed by HC. Therefore, the HC study could have been
misleadingly reassuring to the referring physician as it
reported normal wall motion.
Our major finding was that compared to SE, the HC
device missed a significant finding in 36 critically ill patients
(45%). The primary reasons for this were lack of sensitivity
of the color power Doppler feature as compared to color
Doppler flow imaging on SE for the detection of significant
valvular regurgitation (14 patients), image-quality problems,
leading to underdiagnosis of LVF (7 patients), pericardial
tamponade (1 patient), and intracardiac thrombus (1 pa-
tient). In addition, the lack of a spectral Doppler feature is
clearly a limitation of the HC system as currently config-
ured, as demonstrated by the fact that important findings
were not detected in 20 patients.
Study limitations. It is possible that clinical findings may
have been missed by both HC and SE. In addition,
although the reviewers were blinded to the results of the
other study, they were not blinded to the type of machine
used to record the study they were reviewing, as it was
obvious from the taped images. This could have introduced
bias. In addition, this study did not evaluate outcomes or the
potential effect of HC or SE on patient management.
Conclusions. Hand-carried ultrasound technology has the
potential to provide rapid, readily available and important
clinical information in critically ill patients. Although the
HC device was able to provide important anatomic infor-
mation, the device falls far short of SE in the evaluation of
critically ill patients. It is hoped that improvements in
miniaturization techniques will lead to improved imaging
and Doppler capabilities.
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